Azarga Европска Унија - Италијански - EMA (European Medicines Agency)

azarga

novartis europharm limited - brinzolamide, timolol maleate - glaucoma, open-angle; ocular hypertension - oftalmologici - diminuzione della pressione intraoculare (pio) nei pazienti adulti con glaucoma ad angolo aperto o ipertensione oculare per i quali la monoterapia offre una riduzione della pio insufficiente.

Simbrinza Европска Унија - Италијански - EMA (European Medicines Agency)

simbrinza

novartis europharm limited - brinzolamide, brimonidine tartrate - ocular hypertension; glaucoma, open-angle - oftalmologici - diminuzione della pressione intraoculare elevata (pio) nei pazienti adulti con glaucoma ad angolo aperto o ipertensione oculare per i quali la monoterapia offre una riduzione della pio insufficiente.

Zydelig Европска Унија - Италијански - EMA (European Medicines Agency)

zydelig

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Libtayo Европска Унија - Италијански - EMA (European Medicines Agency)

libtayo

regeneron ireland designated activity company (dac) - cemiplimab - carcinoma, cellule squamose - agenti antineoplastici - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Poteligeo Европска Унија - Италијански - EMA (European Medicines Agency)

poteligeo

kyowa kirin holdings b.v. - mogamulizumab - sezary syndrome; mycosis fungoides - agenti antineoplastici - poteligeo è indicato per il trattamento di pazienti adulti affetti da micosi fungoide (mf) o sindrome di sézary (ss) che hanno ricevuto almeno una precedente terapia sistemica.

SUPPOSTE GLICERINA AD 18SUPP Италија - Италијански - AIFA (Agenzia Italiana del Farmaco)

supposte glicerina ad 18supp

johnson & johnson spa - glicerolo - supposte - "adulti 2720 mg supposte" 18 supposte

QUIXIL SOL NEBUL 2F 1ML Италија - Италијански - AIFA (Agenzia Italiana del Farmaco)

quixil sol nebul 2f 1ml

johnson & johnson medical spa - proteina coagulabile umana/trombina umana/calcio cloruro - soluz.per adesivo tissutale - 2 fiale di soluzione da nebulizzare da 1 ml con dispositivo spray - local hemostatics

QUIXIL SOL NEBUL 2F 2ML Италија - Италијански - AIFA (Agenzia Italiana del Farmaco)

quixil sol nebul 2f 2ml

johnson & johnson medical spa - proteina coagulabile umana/trombina umana/calcio cloruro - soluz.per adesivo tissutale - 2 fiale di soluzione da nebulizzare da 2 ml con dispositivo spray - local hemostatics